Rheumatology Advance Access published online on February 3, 2004
Rheumatology, doi:10.1093/rheumatology/keh077
Rheumatology © British Society for Rheumatology 2004; all rights reserved
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original Papers
1 Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan; Second Department of Oral and Maxillo-facial Surgery, Kyushu Dental College, 2-6-1 Manazuru, Kokurakita-ku, Kitakyushu, Fukuoka 803-8580, Japan
* Corresponding author. E-mail: t-ochi{at}sagamihara-hosp.gr.jp.
Received 23 March 2003
; accepted 17 October 2003
Objective. To investigate the morphology and function of multinucleated bone-resorbing giant cells derived from CD14-positive cells in the synovial fluids (SF) of patients with rheumatoid arthritis (RA) or osteoarthritis (OA). Methods. CD14-positive cells were obtained by magnetic-activated cell sorting of primary cultures of mononuclear cells from the SF. Multinucleated bone-resorbing giant cells were induced from the CD14-positive cells in the presence or absence of cytokines. We examined various characteristics, including osteoclast markers, fusion index and bone-resorption activities of the multinucleated giant cells. Results. Multinucleated giant cells were induced from the CD14-positive cells in the SF of the RA and OA patients by the addition of interleukin (IL)-3, IL-5 and IL-7, or granulocyte-macrophage colony-stimulating factor (GM-CSF), respectively. These multinucleated giant cells were positive for tartrate-resistant acid phosphatase (TRAP), carbonic anhydrase II, actin, vitronectin receptor and the calcitonin receptor. However, the average values for the number of nuclei, fusion index and bone-resorption functions of the SF cells from the RA patients were significantly higher than those derived from the OA patients. Conclusion. These results suggest that the induction and activities of multinucleated bone-resorbing giant cells may play a pivotal role in bone destruction, and that these processes may be enhanced significantly in RA patients.
Key words: Rheumatoid arthritis, Synovial fluid, CD14-positive cell, Osteoclast.
Comparison of the activities of multinucleated bone-resorbing giant cells derived from CD14-positive cells in the synovial fluids of rheumatoid arthritis and osteoarthritis patients
2 Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan
3 Research Unit of Immunology, Shionogi Institute for Medical Science, Shionogi & Co., Ltd, 2-5-1, Mishima, Settu, Osaka 566-0022, Japan
4 Second Department of Oral and Maxillo-facial Surgery, Kyushu Dental College, 2-6-1 Manazuru, Kokurakita-ku, Kitakyushu, Fukuoka 803-8580, Japan
5 Clinical Research Center for Allergy and Rheumatology, National Sagamihara Hospital, 18-1 Sakura-dai, Sagamihara, Kanagawa 228-8522, Japan
6 Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka 565-0871; Clinical Research Center for Allergy and Rheumatology, National Sagamihara Hospital, 18-1 Sakura-dai, Sagamihara, Kanagawa 228-8522, Japan
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. M. Churchman and F. Ponchel Interleukin-7 in rheumatoid arthritis Rheumatology, June 1, 2008; 47(6): 753 - 759. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Take, Y. Kobayashi, Y. Yamamoto, H. Tsuboi, T. Ochi, S. Uematsu, N. Okafuji, S. Kurihara, N. Udagawa, and N. Takahashi Prostaglandin E2 Strongly Inhibits Human Osteoclast Formation Endocrinology, December 1, 2005; 146(12): 5204 - 5214. [Abstract] [Full Text] [PDF]
|
|